A detailed history of Geode Capital Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,040,218 shares of HUMA stock, worth $9.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,040,218
Previous 1,861,098 9.62%
Holding current value
$9.87 Million
Previous $8.93 Million 24.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.11 - $9.46 $915,303 - $1.69 Million
179,120 Added 9.62%
2,040,218 $11.1 Million
Q2 2024

Aug 09, 2024

BUY
$2.87 - $9.1 $1.47 Million - $4.65 Million
510,560 Added 37.8%
1,861,098 $8.93 Million
Q1 2024

May 13, 2024

BUY
$2.57 - $4.84 $63,897 - $120,336
24,863 Added 1.88%
1,350,538 $4.2 Million
Q4 2023

Feb 13, 2024

BUY
$1.99 - $3.12 $192,226 - $301,379
96,596 Added 7.86%
1,325,675 $3.76 Million
Q3 2023

Nov 13, 2023

BUY
$2.75 - $4.48 $349,558 - $569,461
127,112 Added 11.54%
1,229,079 $3.6 Million
Q2 2023

Aug 11, 2023

BUY
$2.86 - $4.97 $137,377 - $238,728
48,034 Added 4.56%
1,101,967 $3.15 Million
Q1 2023

May 15, 2023

BUY
$2.11 - $3.25 $377,145 - $580,911
178,742 Added 20.42%
1,053,933 $3.26 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.62 $390,655 - $700,086
193,394 Added 28.37%
875,191 $1.85 Million
Q3 2022

Nov 14, 2022

SELL
$1.22 - $5.14 $117,364 - $494,467
-96,200 Reduced 12.37%
681,797 $2.22 Million
Q2 2022

Aug 12, 2022

BUY
$3.21 - $7.86 $572,047 - $1.4 Million
178,208 Added 29.71%
777,997 $2.5 Million
Q1 2022

May 13, 2022

SELL
$4.65 - $7.4 $21,031 - $33,470
-4,523 Reduced 0.75%
599,789 $4.23 Million
Q4 2021

Feb 11, 2022

BUY
$7.25 - $11.6 $4.16 Million - $6.65 Million
573,380 Added 1853.68%
604,312 $4.38 Million
Q3 2021

Nov 12, 2021

BUY
$9.21 - $16.99 $284,883 - $525,534
30,932 New
30,932 $359,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $499M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.